Frontiers | G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer | Endocrinology
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS
Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages | The Journal of Immunology
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance | Oncology
Four major mechanisms of estrogen and estrogen receptors (ER). (I)... | Download Scientific Diagram
The many faces of estrogen signaling - Biochemia Medica
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages | The Journal of Immunology
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Cancers | Free Full-Text | Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer | HTML
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Frontiers | Non-canonical Estrogen Signaling in Endocrine Resistance | Endocrinology
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent* - Journal of Biological Chemistry
Fulvestrant | Aromatase inhibitor | Buy Faslodex from Supplier AdooQ®
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER | Endocrinology
Full antagonism of the estrogen receptor without a prototypical ligand side chain | Nature Chemical Biology
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
